NCT02869555
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Institut Paoli-Calmettes Marseille, Bouches-du Rhône, France
Clinical trial condition
Hemostatic Disorders
Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.
3,075 public trials
581 recruiting studies
Hemostatic Disorders trial results
Enrolling by Invitation
Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)
NCT03689595
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
Enrolling by Invitation
International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab
NCT05669989
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Washington University- Site Number : 8400001 St Louis, Missouri, United States
- Investigational Site Number : 0360006 Blacktown, New South Wales, Australia
- Investigational Site Number : 0360001 Saint Leonards, New South Wales, Australia
- Investigational Site Number : 0360003 Wollongong, New South Wales, Australia
Enrolling by Invitation
Gene Therapy Follow-up Protocol for People Previously Enrolled in CAR-T Cell Studies
NCT02473757
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +21 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Enrolling by Invitation
Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event
NCT07499128
- Conditions
- Antibodies Bispecific, Blood Protein Disorders, Body Temperature, +36 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Enrolling by Invitation
Long-Term Follow-up Study
NCT05332054
- Conditions
- B Cell Lymphoma, B-cell Non-Hodgkin's Lymphoma, Blood Protein Disorders, +29 more
- Locations
-
- University of Alabama Birmingham, Alabama, United States
- Banner MD Anderson Cancer Center Gilbert, Arizona, United States
- Honor Health Research Institute Scottsdale, Arizona, United States
- University of California Irvine Irvine, California, United States
Enrolling by Invitation
Efficacy and Tolerance of Treatment With Bevacizumab for Severe Liver Involvement With High Cardiac Output in Hereditary Hemorrhagic Telangiectasia Within the French Hereditary Hemorrhagic Telangiectasia Network
NCT07445347
- Conditions
- Bevacizumab, Cardiovascular Abnormalities, Cardiovascular Diseases, +16 more
- Locations
-
- Centre hospitalier universitaire de Poitiers Poitiers, France
Enrolling by Invitation
AI-Based Fine Morphological Subtyping of Myeloma Single Cells for Predicting FISH Abnormalities
NCT07410403
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Zhongnan Hospital of Wuhan University Wuhan, Hubei, China
Enrolling by Invitation
Watch and Wait or Worry and Wait in Indolent Lymphoma
NCT07173790
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +32 more
- Locations
-
- Samsung Medical Center Seoul, Gangnam-gu, South Korea
- Korea UniversityKorea University Guro Hospital Seoul, Guro-gu, South Korea
- Seoul National University Hospital Seoul, Jongno-gu, South Korea
- The Catholic University of Korea Seoul, Seocho-gu, South Korea
Enrolling by Invitation
Study of HuL001 in Relapsed/Refractory Multiple Myeloma Patients
NCT07210047
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Far Eastern Memorial Hospital Taipei, Taiwan